# Bioequivalence of RYTHMOL SR® Manufactured at Two Different Sites

> **NCT01956487** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 38 (actual)

## Conditions studied

- Arrhythmia, Cardiac

## Interventions

- **DRUG:** Propafenone

## Key facts

- **NCT ID:** NCT01956487
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-04-11
- **Primary completion:** 2012-06-27
- **Final completion:** 2012-06-27
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2017-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01956487

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01956487, "Bioequivalence of RYTHMOL SR® Manufactured at Two Different Sites". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01956487. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*